RxDoctor Payments Data

Diane May, APRN

Psychiatric/Mental Health · Johnstown, PANPI 1851502967

Payments from drug & device makers

$880in general payments, 2019–2025

Across 56 payments — averaging $15.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$388
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$120
  • Johnson & Johnson$106
  • Ironshore Pharmaceuticals Inc.$88
  • Neurocrine Biosciences, Inc.$76
  • Supernus Pharmaceuticals, Inc.$54
  • plus $48 from 2 others

What the payments were for

  • Food & beverage$83194%
  • Education$496%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$880 in reported general payments places this provider in the 60th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.

See all psychiatric/mental health providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$1,376
Medicare patients
14
Services billed
18

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl13$18,230
Quetiapine Fumarate46$1,014
Aripiprazole19$803
Divalproex Sodium12$622
Bupropion XlBupropion Hcl21$606
Venlafaxine Hcl ErVenlafaxine Hcl25$591
Oxcarbazepine23$538
Sertraline Hcl43$536
Mirtazapine18$506
Duloxetine Hcl19$446
Gabapentin32$416
Alprazolam35$382
Trazodone Hcl40$365
Lamotrigine22$343
Lorazepam55$341

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$388$18,23013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.

Other psychiatric/mental health in Johnstown

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →